Cargando…

Intravitreal Injection of Dexamethasone Implant in Serous Macular Detachment Associated with Waldenström's Disease

PURPOSE: To evaluate the efficacy of one intravitreal injection of dexamethasone (Ozurdex(®); Allergan, Inc., Irvine, Calif., USA) in serous macular detachment (SMD) of one eye, associated with bilateral central retinal vein occlusion (CRVO) in a patient affected by Waldenström's macroglobuline...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenicia, Vito, Balestrieri, Marco, Perdicchi, Andrea, Maraone, Giorgia, Recupero, Santi Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764974/
https://www.ncbi.nlm.nih.gov/pubmed/24019788
http://dx.doi.org/10.1159/000354066

Ejemplares similares